NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Aravive Inc (NASDAQ: ARAV)
ARAV Technical Analysis
2
As on 9th Jun 2023 ARAV STOCK Price closed @ 1.65 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.45 & Strong Sell for SHORT-TERM with Stoploss of 2.29 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ARAVSTOCK Price
Open | 1.74 | Change | Price | % |
High | 1.77 | 1 Day | -0.06 | -3.51 |
Low | 1.65 | 1 Week | 0.07 | 4.43 |
Close | 1.65 | 1 Month | 0.07 | 4.43 |
Volume | 244865 | 1 Year | -1.13 | -40.65 |
52 Week High 2.78 | 52 Week Low 0.61 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
ARAV Daily Charts |
ARAV Intraday Charts |
Whats New @ Bazaartrend |
ARAV Free Analysis |
|
ARAV Important Levels Intraday
RESISTANCE | 1.88 |
RESISTANCE | 1.81 |
RESISTANCE | 1.76 |
RESISTANCE | 1.72 |
SUPPORT | 1.58 |
SUPPORT | 1.54 |
SUPPORT | 1.49 |
SUPPORT | 1.42 |
ARAV Forecast May 2024
4th UP Forecast | 3.42 |
3rd UP Forecast | 2.85 |
2nd UP Forecast | 2.5 |
1st UP Forecast | 2.15 |
1st DOWN Forecast | 1.15 |
2nd DOWN Forecast | 0.8 |
3rd DOWN Forecast | 0.45 |
4th DOWN Forecast | -0.12 |
ARAV Weekly Forecast
4th UP Forecast | 2.67 |
3rd UP Forecast | 2.34 |
2nd UP Forecast | 2.14 |
1st UP Forecast | 1.94 |
1st DOWN Forecast | 1.36 |
2nd DOWN Forecast | 1.16 |
3rd DOWN Forecast | 0.96 |
4th DOWN Forecast | 0.63 |
ARAV Forecast2024
4th UP Forecast | 6.01 |
3rd UP Forecast | 4.61 |
2nd UP Forecast | 3.75 |
1st UP Forecast | 2.88 |
1st DOWN Forecast | 0.42 |
2nd DOWN Forecast | -0.45 |
3rd DOWN Forecast | -1.31 |
4th DOWN Forecast | -2.71 |
Aravive Inc ( NASDAQ USA Symbol : ARAV )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ARAV Other Details
Segment | EQ | |
Market Capital | 75191824.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
ARAV Address
ARAV Latest News
ARAV Business Profile
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases. Its lead product candidate is AVB-500, a decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase Ib/II clinical trial for the treatment of platinum- resistant recurrent ovarian cancer, as well as for the treatment of clear cell renal cell carcinoma, HER negative breast cancer, uterine, pancreatic cancer, urothelial, and non-small-cell lung cancers. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a strategic collaboration agreement with WuXi Biologics to develop novel high-affinity bispecific antibodies targeting cancer and fibrosis; and license agreement with 3D Medicines Inc. to develop products that contain AVB-500 as the sole drug substance for the treatment of human oncological diseases in mainland China, Taiwan, Hong Kong, and Macau. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. is headquartered in Houston, Texas. Address: River Oaks Tower, Houston, TX, United States, 77098
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service